company background image
ISRG

Intuitive SurgicalNasdaqGS:ISRG Stock Report

Market Cap

US$122.4b

7D

1.0%

1Y

58.9%

Updated

23 Sep, 2021

Data

Company Financials +
ISRG fundamental analysis
Snowflake Score
Valuation0/6
Future Growth2/6
Past Performance5/6
Financial Health6/6
Dividends0/6

ISRG Overview

Intuitive Surgical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets da Vinci surgical systems, and related instruments and accessories in the United States and internationally.

Rewards

Earnings are forecast to grow 10.4% per year

Earnings grew by 42.8% over the past year

Risk Analysis

No risks detected for ISRG from our risk checks.

Intuitive Surgical Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Intuitive Surgical
Historical stock prices
Current Share PriceUS$1,044.84
52 Week HighUS$647.54
52 Week LowUS$1,087.01
Beta1.05
1 Month Change-0.18%
3 Month Change15.03%
1 Year Change58.90%
3 Year Change83.41%
5 Year Change335.36%
Change since IPO17,253.75%

Recent News & Updates

Shareholder Returns

ISRGUS Medical EquipmentUS Market
7D1.0%-0.2%-0.5%
1Y58.9%40.4%37.5%

Return vs Industry: ISRG exceeded the US Medical Equipment industry which returned 37.7% over the past year.

Return vs Market: ISRG exceeded the US Market which returned 36.2% over the past year.

Price Volatility

Is ISRG's price volatile compared to industry and market?
ISRG volatility
ISRG Beta1.05
Industry Beta0.88
Market Beta1

Stable Share Price: ISRG is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 3% a week.

Volatility Over Time: ISRG's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19958,081Gary Gutharthttps://www.intuitive.com

Intuitive Surgical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets da Vinci surgical systems, and related instruments and accessories in the United States and internationally. The company’s da Vinci Surgical System include surgeon’s consoles, patient-side carts, 3-D HD vision systems, skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures. It also manufactures EndoWrist instruments, such as forceps, scissors, electrocautery tools, scalpels, and other surgical tools, which incorporate wrist joints for natural dexterity for various surgical procedures; and provides SimNow, a cloud-enabled simulation platform, which allows surgeons to learn and practice their surgical skills; Iris, an augmented reality imaging product for use in kidney procedures; and Intuitive Cloud that enables proactive monitoring and software updates.

Intuitive Surgical Fundamentals Summary

How do Intuitive Surgical's earnings and revenue compare to its market cap?
ISRG fundamental statistics
Market CapUS$122.38b
Earnings (TTM)US$1.62b
Revenue (TTM)US$5.16b

76.6x

P/E Ratio

24.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
ISRG income statement (TTM)
RevenueUS$5.16b
Cost of RevenueUS$1.62b
Gross ProfitUS$3.55b
ExpensesUS$1.92b
EarningsUS$1.62b

Last Reported Earnings

Jun 30, 2021

Next Earnings Date

Oct 19, 2021

Earnings per share (EPS)13.77
Gross Margin68.69%
Net Profit Margin31.43%
Debt/Equity Ratio0.0%

How did ISRG perform over the long term?

See historical performance and comparison

Valuation

Is Intuitive Surgical undervalued compared to its fair value and its price relative to the market?

76.62x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: ISRG ($1044.84) is trading above our estimate of fair value ($670.34)

Significantly Below Fair Value: ISRG is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: ISRG is poor value based on its PE Ratio (76.6x) compared to the US Medical Equipment industry average (51.1x).

PE vs Market: ISRG is poor value based on its PE Ratio (76.6x) compared to the US market (17.7x).


Price to Earnings Growth Ratio

PEG Ratio: ISRG is poor value based on its PEG Ratio (7.4x)


Price to Book Ratio

PB vs Industry: ISRG is overvalued based on its PB Ratio (11.5x) compared to the US Medical Equipment industry average (4.7x).


Future Growth

How is Intuitive Surgical forecast to perform in the next 1 to 3 years based on estimates from 19 analysts?

10.4%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: ISRG's forecast earnings growth (10.4% per year) is above the savings rate (2%).

Earnings vs Market: ISRG's earnings (10.4% per year) are forecast to grow slower than the US market (14.9% per year).

High Growth Earnings: ISRG's earnings are forecast to grow, but not significantly.

Revenue vs Market: ISRG's revenue (12.5% per year) is forecast to grow faster than the US market (9.8% per year).

High Growth Revenue: ISRG's revenue (12.5% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: ISRG's Return on Equity is forecast to be low in 3 years time (14.9%).


Past Performance

How has Intuitive Surgical performed over the past 5 years?

14.3%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: ISRG has high quality earnings.

Growing Profit Margin: ISRG's current net profit margins (31.4%) are higher than last year (26.1%).


Past Earnings Growth Analysis

Earnings Trend: ISRG's earnings have grown by 14.3% per year over the past 5 years.

Accelerating Growth: ISRG's earnings growth over the past year (42.8%) exceeds its 5-year average (14.3% per year).

Earnings vs Industry: ISRG earnings growth over the past year (42.8%) exceeded the Medical Equipment industry 40.5%.


Return on Equity

High ROE: ISRG's Return on Equity (15.1%) is considered low.


Financial Health

How is Intuitive Surgical's financial position?


Financial Position Analysis

Short Term Liabilities: ISRG's short term assets ($6.0B) exceed its short term liabilities ($1.0B).

Long Term Liabilities: ISRG's short term assets ($6.0B) exceed its long term liabilities ($412.9M).


Debt to Equity History and Analysis

Debt Level: ISRG is debt free.

Reducing Debt: ISRG has not had any debt for past 5 years.

Debt Coverage: ISRG has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: ISRG has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Dividend

What is Intuitive Surgical current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate ISRG's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate ISRG's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if ISRG's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if ISRG's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of ISRG's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

6.7yrs

Average management tenure


CEO

Gary Guthart (55 yo)

11.67yrs

Tenure

US$6,043,362

Compensation

Dr. Gary S. Guthart, Ph D., has been Chief Executive Officer of Intuitive Surgical, Inc. since January 1, 2010 and its President since July 12, 2007. Dr. Guthart served as the Chief Operating Officer at In...


CEO Compensation Analysis

Compensation vs Market: Gary's total compensation ($USD6.04M) is below average for companies of similar size in the US market ($USD11.36M).

Compensation vs Earnings: Gary's compensation has been consistent with company performance over the past year.


Leadership Team

Experienced Management: ISRG's management team is seasoned and experienced (6.7 years average tenure).


Board Members

Experienced Board: ISRG's board of directors are considered experienced (4.4 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Intuitive Surgical, Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: Intuitive Surgical, Inc.
  • Ticker: ISRG
  • Exchange: NasdaqGS
  • Founded: 1995
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: US$122.378b
  • Shares outstanding: 118.99m
  • Website: https://www.intuitive.com

Number of Employees


Location

  • Intuitive Surgical, Inc.
  • 1020 Kifer Road
  • Sunnyvale
  • California
  • 94086-5304
  • United States

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/09/23 22:54
End of Day Share Price2021/09/23 00:00
Earnings2021/06/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.